diabetic%20ketoacidosis%20-and-%20hyperosmolar%20hyperglycemic%20state
DIABETIC KETOACIDOSIS & HYPEROSMOLAR HYPERGLYCEMIC STATE
Diabetic ketoacidosis is characterized by having blood glucose >13.9 mmol/L, arterial pH <7.3 in adults or venous pH <7.3 in pediatrics, bicarbonate <15 mEg/L, moderate ketonuria or ketonemia and anion gap >14.
Hyperosmolar hyperglycemic state in adults is described as having blood glucose >33.3 mmol/L, arterial pH >7.3, bicarbonate >15 mEq/L, mild ketonuria or ketonemia, effective serum osmolality >320 mOsm/kg and variable anion gap.
Hyperosmolar hyperglycemic state in pediatric patients has blood glucose >33.3 mmol/L, venous pH >7.3, bicarbonate >15 mEq/L and altered mental status or severe dehydration.

Pharmacotherapy

  • DKA & HHS patients are best managed in the intensive care unit w/ the care of a specialist/endocrinologist

Intravenous (IV) Fluids

  • Initial therapy aims to restore renal perfusion, & expand intravascular & extravascular volume
  • Fluid deficits should be corrected w/in the first 24 hours of treatment
  • Serum Na should be corrected for hyperglycemia (for each 5.6 mmol/L glucose >5.6 mmol/L, add 1.6 mmol to Na value for corrected serum Na value)
  • Serum osmolality change should not be >3 mOsm/kg H2O/hour
  • Avoid iatrogenic fluid overload by frequently monitoring cardiac, renal & mental status
  • In pediatric patients, initial fluid expansion should not be >50 mL/kg over first 4 hours of treatment
    • Fluid deficits should be corrected over 48 hours of treatment

Insulin

  • Ketonemia usually takes longer to clear than hyperglycemia
  • May or may not be aggressive w/ insulin administration depending on patient hydration
  • If patient presents w/ severe hypokalemia, insulin treatment should be delayed until K serum concentration is restored to >3.3 mmol/L to avoid respiratory arrest & arrhythmias
  • There should be an overlap of IV insulin & subcutaneous (SC) insulin of 1-2 hours to ensure adequate glucose control
    • An abrupt discontinuation of IV insulin w/ a delayed onset of SC insulin may result in inadequate glucose control
  • In newly diagnosed diabetics the initial total insulin dose should be ~0.5-1 U/kg/day given in ≥2 divided doses
    • Include both short-acting & long-acting insulin
    • Continue until optimal dosing is established

Potassium

  • Correction of acidosis, volume expansion & insulin therapy decrease serum K concentration
    • Hypokalemia may be avoided by K replacement 

Bicarbonate

  • Studies have failed to show benefit or deleterious changes in morbidity or mortality w/ bicarbonate use in diabetic ketoacidosis (DKA) patients w/ pH between 6.9-7.1
  • Insulin & bicarbonate can lower serum K & supplementation may be required

Phosphate

  • Patients w/ cardiac dysfunction, anemia or respiratory depression may benefit from careful phosphate replacement
    • Hypophosphatemia may cause cardiac & skeletal muscle weakness, & respiratory depression

Somatostatin

  • Though not considered standard therapy, Somatostatin may be added if patients are resistant to conventional DKA therapy
  • Effects: Decrease glucagon secretion & inhibit ketogenesis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 28 Jan 2020

Individuals with type 2 diabetes (T2D) who are prescribed an SGLT2* inhibitor may have a reduced risk for developing gout compared with those who are prescribed a GLP-1** receptor agonist, according to a study from the US.

10 Feb 2020
Pregnant women with thyroiditis may do well with selenium supplementation, which confers benefits for autoantibody titre during pregnancy and thyroiditis recurrence postpartum, as shown in a study.
Jairia Dela Cruz, 27 Jan 2020
Bariatric surgery is beneficial to nondiabetic Asian patients with obesity, delivering sustained weight loss in addition to normalizing sugar levels and insulin resistance within 1–3 years of the procedure, as reported in a Singapore study.
15 Feb 2020
Sleep disorder in nonstandard shift workers appears to contribute to more severe hypogonadal symptoms and lower testosterone levels when compared with daytime workers and nonstandard shift workers without sleep disorder, according to a study.